Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis

By Suzuki Daisuke  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 782-785

Springer Publishing Company

Access to resources Recommend Favorite

The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4

By Dror Y.  

Experimental Hematology, Vol. 31, Iss. 3, 2003-03 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia

By Anargyrou Konstantinos   Vaiopoulos George   Terpos Evangelos   Tsironi Maria   Konstantopoulos Konstantinos   Samarkos Michael   Meletis John  

Haematologia, Vol. 32, Iss. 2, 2002-06 ,pp. : 169-173

VSP

Access to resources Recommend Favorite

Hyponatremia after administration of conditioning regimen in myelodysplastic syndrome with empty sella after glandula pituitaria surgery

By Tsutsumi Yutaka  

Annals of Hematology, Vol. 86, Iss. 11, 2007-11 ,pp. : 843-844

Springer Publishing Company

Access to resources Recommend Favorite

Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia

By Erikci Alev Akyol   Ozturk Ahmet   Karagoz Bulent   Bilgi Oguz   Turken Orhan   Top Cihan   Kandemir E. Gokhan  

Hematology, Vol. 13, Iss. 5, 2008-10 ,pp. : 289-292

Maney Publishing

Access to resources Recommend Favorite